These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39156174)

  • 1. Economic Evaluation of an Integrated Care Program Compared to Conventional Care for Patients With Chronic Kidney Disease in Rural Communities of Thailand.
    Paffett M; Phannajit J; Chavarina KK; Chuanchaiyakul T; Jiamjariyapon T; Thanachayanont T; Chanpitakkul M; Lekagul S; Teerawattananon Y; Tungsanga K
    Kidney Int Rep; 2024 Aug; 9(8):2546-2558. PubMed ID: 39156174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of Integrated Care on Delaying Progression of stage 3-4 Chronic Kidney Disease in Rural Communities of Thailand (ESCORT study): a cluster randomized controlled trial.
    Jiamjariyapon T; Ingsathit A; Pongpirul K; Vipattawat K; Kanchanakorn S; Saetie A; Kanistanon D; Wongprompitak P; Leesmidt V; Watcharasaksilp W; Wang W; Chandraker AK; Tungsanga K
    BMC Nephrol; 2017 Mar; 18(1):83. PubMed ID: 28253839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients.
    Sangmala P; Chaikledkaew U; Tanwandee T; Pongchareonsuk P
    Asian Pac J Cancer Prev; 2014; 15(20):8993-9004. PubMed ID: 25374242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease.
    Pouwels XGLV; van Mil D; Kieneker LM; Boersma C; van Etten RW; Evers-Roeten B; Heerspink HJL; Hemmelder MH; Langelaan MLP; Thelen MHM; Gansevoort RT; Koffijberg H
    EClinicalMedicine; 2024 Feb; 68():102414. PubMed ID: 38299045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Utility and Cost-Effectiveness Analysis of Spinal Cord Stimulation for Chronic Refractory Pain in the Context of Developing Country.
    Zinboonyahgoon N; Saengsomsuan N; Chaikittiporn N; Wangnamthip S; Kositamongkol C; Phisalprapa P
    Pain Physician; 2023 Jan; 26(1):69-79. PubMed ID: 36791296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness and budget impact of universal varicella vaccination in Russia.
    Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
    Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
    BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT-2) trials.
    Thanachayanont T; Chanpitakkul M; Hengtrakulvenit J; Watcharakanon P; Wisansak W; Tancharoensukjit T; Kaewsringam P; Leesmidt V; Pongpirul K; Lekagul S; Tungsanga K;
    Nephrology (Carlton); 2021 Apr; 26(4):333-340. PubMed ID: 33442912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Utility Analysis of the Integrated Care Models for the Management of Hypertension Patients: A Quasi-Experiment in Southwest Rural China.
    Ke X; Zhang L; Tang W
    Front Public Health; 2021; 9():727829. PubMed ID: 34966712
    [No Abstract]   [Full Text] [Related]  

  • 12. CKDNET, a quality improvement project for prevention and reduction of chronic kidney disease in the Northeast Thailand.
    Cha'on U; Wongtrangan K; Thinkhamrop B; Tatiyanupanwong S; Limwattananon C; Pongskul C; Panaput T; Chalermwat C; Lert-Itthiporn W; Sharma A; Anutrakulchai S;
    BMC Public Health; 2020 Aug; 20(1):1299. PubMed ID: 32854662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of the SMART quit clinic program in smokers with cardiovascular disease in Thailand.
    Grant A; Tan CJ; Wattanasirichaigoon S; Rungruanghiranya S; Thongphiew A; Thavorn K; Chaiyakunapruk N
    Tob Induc Dis; 2023; 21():47. PubMed ID: 37035838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn's disease using real world evidence in Thailand.
    Phisalprapa P; Kositamongkol C; Limsrivilai J; Aniwan S; Charatcharoenwitthaya P; Pisespongsa P; Kitiyakara T; Treepongkaruna S; Chaiyakunapruk N
    J Med Econ; 2020 Nov; 23(11):1302-1310. PubMed ID: 32729347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial.
    Lim AG; Aas CF; Çağlar ES; Vold JH; Fadnes LT; Vickerman P; Johansson KA
    Addiction; 2023 Dec; 118(12):2424-2439. PubMed ID: 37515462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of the screening program for early oral cancer detection in Thailand.
    Kumdee C; Kulpeng W; Teerawattananon Y
    PLoS One; 2018; 13(11):e0207442. PubMed ID: 30496214
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.